>
C-Mer Eye Care Holdings logo

3309 - C-Mer Eye Care Holdings Share Price

HK$5.59 -0.1  -1.2%

Last Trade - 07/05/21

Sector
Healthcare
Size
Mid Cap
Market Cap £595.2m
Enterprise Value £566.8m
Revenue £64.9m
Position in Universe 1208th / 6094
Bullish
Bearish
Unlock 3309 Revenue
Momentum
Relative Strength (%)
1m -1.23%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -33.6%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
198.9 248.7 311.2 429.4 576.2 699.5 +28.6%
+71.6 +22.1 +24.7 -42.6 -7.1
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, C-MerEye Care Holdings Ltd revenues increased 21% to HK$699.5M.Net loss totaled HK$6.2M vs. income of HK$41.4M. Revenuesreflect Provision of ophthalmic services segment increaseof 15% to HK$605.6M, Sales of vision aid products segmentincrease of 97% to HK$93.9M, People's Republic of Chinasegment increase of 23% to HK$359.6M, Hong Kong segmentincrease of 19% to HK$339.9M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for 3309
Graphical History

Revenue

3309 Revenue Unlock 3309 Revenue

Net Income

3309 Net Income Unlock 3309 Revenue

Normalised EPS

3309 Normalised EPS Unlock 3309 Revenue

PE Ratio Range

3309 PE Ratio Range Unlock 3309 Revenue

Dividend Yield Range

3309 Dividend Yield Range Unlock 3309 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
3309 EPS Forecasts Unlock 3309 Revenue
Profile Summary

C-MER Eye Care Holdings Limited is an investment holding company principally engaged in the provision of ophthalmic services, sale of vision aid and pharmaceutical products. The ophthalmic services are surgeries for the treatment of cataract, glaucoma and strabismus, as well as eye diseases, including corneal and vitreoretinal diseases. The Company also sells vision aid products including glasses and lens, as well as pharmaceutical products. The Company's main subsidiaries are C-MER Eye Care Medical Group Limited and C-MER Eye Care Group Limited, among others.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated February 1, 2016
Public Since January 15, 2018
No. of Shareholders: n/a
No. of Employees: 1,058
Sector Healthcare
Industry Healthcare Providers & Services
Index Hang Seng Composite , Hang Seng Composite Mid & SmallCap , Hang Seng Composite SmallCap ,
Exchange Stock Exchange of Hong Kong Limited
Shares in Issue 1,148,392,203
Free Float (0.0%)
Eligible for
ISAs
SIPPs
+
Address , Hong Kong
Web http://www.cmereye.com/
Phone +852 39973266
Contact ()
Auditors PricewaterhouseCoopers
3309 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 3309
Upcoming Events for 3309
Wednesday 19th May, 2021 Estimate
C-Mer Eye Care Holdings Ltd Annual Shareholders Meeting
Wednesday 26th May, 2021
C-Mer Eye Care Holdings Ltd Annual Shareholders Meeting
Monday 31st May, 2021
Dividend For 3309.HK - 0.0200 HKD
Frequently Asked Questions for C-Mer Eye Care Holdings
What is the C-Mer Eye Care Holdings share price?

As of 07/05/21, shares in C-Mer Eye Care Holdings are trading at HK$5.59, giving the company a market capitalisation of £595.2m. This share price information is delayed by 15 minutes.

How has the C-Mer Eye Care Holdings share price performed this year?

Shares in C-Mer Eye Care Holdings are currently trading at HK$5.59 and the price has moved by 40.45% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the C-Mer Eye Care Holdings price has moved by -11.16% over the past year.

What are the analyst and broker recommendations for C-Mer Eye Care Holdings?

Of the analysts with advisory recommendations for C-Mer Eye Care Holdings, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for C-Mer Eye Care Holdings is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will C-Mer Eye Care Holdings next release its financial results?

C-Mer Eye Care Holdings is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the C-Mer Eye Care Holdings dividend yield?

The C-Mer Eye Care Holdings dividend yield is 0.36% based on the trailing twelve month period.

Does C-Mer Eye Care Holdings pay a dividend?

Last year, C-Mer Eye Care Holdings paid a total dividend of 0.02, and it currently has a trailing dividend yield of 0.36%. Looking ahead, shares in C-Mer Eye Care Holdings are due to go ex-dividend on 2021-05-31 and the next dividend pay date is 2021-06-28.

When does C-Mer Eye Care Holdings next pay dividends?

C-Mer Eye Care Holdings are due to go ex-dividend on 2021-05-31 and the next dividend pay date is 2021-06-28. The historic dividend yield on C-Mer Eye Care Holdings shares is currently 0.36%.

How do I buy C-Mer Eye Care Holdings shares?

To buy shares in C-Mer Eye Care Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of C-Mer Eye Care Holdings?

Shares in C-Mer Eye Care Holdings are currently trading at HK$5.59, giving the company a market capitalisation of £595.2m.

Where are C-Mer Eye Care Holdings shares listed? Where are C-Mer Eye Care Holdings shares listed?

Here are the trading details for C-Mer Eye Care Holdings:

Country of listing: Hong Kong
Exchange: HKG
Ticker Symbol: 3309
What kind of share is C-Mer Eye Care Holdings?

Based on an overall assessment of its quality, value and momentum, C-Mer Eye Care Holdings is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a C-Mer Eye Care Holdings share price forecast 2021?

Shares in C-Mer Eye Care Holdings are currently priced at HK$5.59. At that level they are trading at 14.13% premium to the analyst consensus target price of 0.00.

How can I tell whether the C-Mer Eye Care Holdings share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like C-Mer Eye Care Holdings. Over the past six months, the relative strength of its shares against the market has been -15.3%. At the current price of HK$5.59, shares in C-Mer Eye Care Holdings are trading at -6.24% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the C-Mer Eye Care Holdings PE Ratio?

We were not able to find PE ratio data for C-Mer Eye Care Holdings.

Who are the key directors of C-Mer Eye Care Holdings?

We were unable to find the directors for C-Mer Eye Care Holdings.

Who are the major shareholders of C-Mer Eye Care Holdings?

Here are the top five shareholders of C-Mer Eye Care Holdings based on the size of their shareholding:

C-MER Group Ltd Corporation
Percentage owned: 60.41% (693.7m shares)
Lee (Yau Wing Vincent) Individual Investor
Percentage owned: 1.13% (13.0m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 0.8% (9.14m shares)
Vanguard Total International Stock Index Fund Mutual Fund
Percentage owned: 0.42% (4.84m shares)
Chan (Chi Leong) Individual Investor
Percentage owned: 0.24% (2.76m shares)
Similar to 3309
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.